ICUI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 36 cases where ICUI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ICUI's RSI Oscillator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on December 17, 2024. You may want to consider a long position or call options on ICUI as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ICUI just turned positive on December 11, 2024. Looking at past instances where ICUI's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ICUI advanced for three days, in of 299 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 55 cases where ICUI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
ICUI moved below its 50-day moving average on November 13, 2024 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICUI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for ICUI entered a downward trend on December 16, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ICUI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.199) is normal, around the industry mean (23.300). ICUI has a moderately high P/E Ratio (333.333) as compared to the industry average of (83.485). Projected Growth (PEG Ratio) (0.991) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.125) is also within normal values, averaging (43.338).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICUI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
a manufacturer of medical technologies
Industry MedicalSpecialties
A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with AXGN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then AXGN could also see price increases.
Ticker / NAME | Correlation To ICUI | 1D Price Change % | ||
---|---|---|---|---|
ICUI | 100% | -1.19% | ||
AXGN - ICUI | 45% Loosely correlated | +1.80% | ||
LMAT - ICUI | 44% Loosely correlated | -1.27% | ||
NEOG - ICUI | 43% Loosely correlated | +2.36% | ||
VCYT - ICUI | 43% Loosely correlated | -2.52% | ||
CERS - ICUI | 43% Loosely correlated | -6.11% | ||
More |